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Abstract
Extracellular UDP-glucose is a natural purinergic receptor agonist, but its mechanisms of cellular
release remain unclear. We studied these mechanisms in Saccharomyces cerevisiae, a simple model
organism that releases ATP, another purinergic agonist. Similar to ATP, UDP-glucose was released
by S. cerevisiae at a rate that was linear over time. However, unlike ATP release, UDP-glucose release
was not dependent on glucose stimulation. This discrepancy was resolved by demonstrating the
apparent glucose stimulation of ATP release reflected glucose-dependent changes in the intracellular
pattern of adenine nucleotides, with AMP release dominating in the absence of glucose. Indeed, total
adenine nucleotide release, like UDP-glucose release, did not vary with glucose concentration over
the short term. The genetic basis of UDP-glucose release was explored through analysis of deletion
mutants, aided by development of a novel bioassay for UDP-glucose based on signaling through
heterologously expressed human P2Y14 receptors. Using this assay, an elevated rate of UDP-glucose
release was demonstrated in mutants lacking the putative Golgi nucleotide sugar transporter
YMD8. An increased rate of UDP-glucose release in ymd8Δ was reduced by deletion of the YEA4
UDP-N-acetylglucosamine or the HUT1 UDP-galactose transporters, and overexpression of YEA4
or HUT1 increased the rate of UDP-glucose release. These findings suggest an exocytotic release
mechanism similar to that of ATP, a conclusion supported by decreased rates of ATP, AMP, and
UDP-glucose release in response to the secretory inhibitor Brefeldin A. These studies demonstrate
the involvement of the secretory pathway in nucleotide and nucleotide sugar efflux in yeast and offer
a powerful model system for further investigation.
Purinergic signaling pathways are present in nearly all mammalian cells (1) and regulate
numerous critical physiologic functions, including control of extracellular volume (2,3) and
inflammatory responses (4–7). The natural agonists of purinergic receptors are extracellular
nucleosides, nucleotides, and nucleotide sugars such as adenosine triphosphate (ATP)1 and
uridine diphosphate (UDP) glucose (UDP-glucose). The physiological actions mediated by
purinergic pathways depend on cellular release of these agonists into the extracellular space.
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However, while vesicular release of ATP has been demonstrated in neuro-endocrine cells (1),
the mechanisms by which ATP, UDP-glucose, and other purinergic agonists exit the cytoplasm
in other cell types remain unclear.
Several mechanisms have been proposed to account for release of purinergic agonists in non-
neuroendocrine cells. ATP release has been most intensively studied in this context, and
conductive efflux through the cystic fibrosis conductance regulator (8,9), connexins (10,11),
a maxi-anion channel (12), and a plasma membrane-localized splice variant of the
mitochondrial voltage-dependent anion channel (13) has been described. Alternatively, ATP
and other purinergic agonists may be released into the extracellular space via exocytosis, a
hypothesis which has experimental support in both mammalian cells (14) and Xenopus oocytes
(15). Similarly, the high concentration of UDP-glucose within the secretory apparatus (16)
suggests that its release mechanism may also be exocytotic (17).
While critical to understanding signaling physiology, elucidation of release mechanisms of
purinergic agonists has been hampered by the limitations of the genetic and biochemical tools
available for studying mammalian and vertebrate cells. Extracellular nucleotide-mediated
signaling has been described in evolutionarily diverse organisms, includinginsects(18,
19),worms(20),andevenplants(21–23), suggesting that mechanisms for release of purinergic
agonists may have early evolutionary origins. Indeed, ATP release has been demonstrated in
a simple model system, the baker’s yeast Saccharomyces cerevisiae (24,25). While yeast do
not naturally express purinergic receptors, they release relatively large quantities of ATP into
the extracellular space in response to glucose. This finding has facilitated exploration of release
mechanisms, with recent determination that the product of the yeast gene MCD4 mediates the
transport of ATP into the Golgi for release via exocytosis (24). These findings suggest that
yeast could serve as a model system for studying the release of other nucleotides or nucleotide
sugars.
This study utilized yeast to study the release mechanisms of UDP-glucose, the natural agonist
of P2Y14 receptors in mammals. Efflux of UDP-glucose from yeast was studied in comparison
to release of ATP and its metabolites (ADP, AMP, and adenosine). Both genetic and
biochemical means were utilized, and these studies were facilitated by development of a UDP-
glucose bioassay based on signaling through heterologous expression of a modified
mammalian P2Y14 receptor (26). Using this bioassay, the effects of a biochemical blockade
of exocytosis and the impact of mutants known to affect accumulation of nucleotide sugars
within the ER and Golgi were examined. These studies helped elucidate the role of exocytosis
and other potential release mechanisms of UDP-glucose and other naturally occurring
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Yeast Strain and Materials
The wild-type strain was BY4741 (MATa his3Δ leu2Δ met15Δ ura3Δ). Yeast knockout (YKO)
mutants were purchased from Research Genetics (Huntsville, AL) and used BY4741 as the
parent strain. The yeast strain used for the UDP-glucose bioassay was CY10981 (PFUS1-HIS3
can1-100 far1Δ1442 his3Δ200 leu2-3,112 lys2 sst2Δ2 ste14::trp1::LYS2 ste3Δ1156 trp1-1
ura3-52) carrying plasmid Cp1021 (PFUS1-LacZ 2 μm URA3) and P2Y14-2211 cloned into
plasmid Cp1651 (PPGK1-hP2Y14 2 μm LEU2) as previously described (26). Brefeldin A was
purchased from Sigma-Aldrich (St. Louis, MO) and 3-aminotriazole from Fisher Scientific
(Pittsburgh, PA).
Extracellular and Intracellular Collections
Yeast were grown overnight in YPD or selective medium, recovered by centrifugation, and
resuspended in 20 mM Tris and 1 mM KH2PO4 (pH 7.6) (TK buffer) with or without
carbohydrate [typically 1% (w/v) glucose] as indicated in the text. Cells were incubated in TK
buffer with or without carbohydrate for 15 min at 30 °C while being shaken, then centrifuged,
and resuspended in TK buffer with or without carbohydrate. Extracellular collections were
obtained at the indicated times and centrifuged for 5 min at 11000g, and supernatants were
recovered and stored on ice. Intracellular collections were obtained by aliquoting 100 μL of
cell suspension in TK buffer in a buffered ethanol solution [41 mL of ethanol and 2 mL of 1
M Tris (pH 7.6)] at 80 °C for 3 min and then transferred to ice. Intracellular collections were
then diluted 1:10 in TK buffer. All collections were boiled for 2 min then stored at –20 °C until
they were analyzed. All results from these samples derived from yeast are presented as the
concentration of nucleotide, nucleoside, or nucleotide sugar divided by cell concentration as
estimated by the optical density at 600 nm (OD600).
Adenine Nucleotide and Nucleoside Detection
Luminometry for ATP was performed as previously described (27) using 30 μL of sample
diluted 1:10 in water and loaded into the autosampler of a LB953 luminometer. One hundred
microliters of the luciferin-luciferase reaction mix was injected and luminescence was recorded
over 10 s and compared to an ATP standard curve performed in parallel. To measure all adenine
nucleotides and nucleosides, etheno derivitization and HPLC were utilized (2). Briefly, 200
μL aliquots of sample were incubated for 30 min at 72 °C in the presence of 1.0 M
chloroacetaldehyde and 25 mM Na2HPO4 (pH 4.0), transferred to ice, alkalinized with 50 μL
of 0.5 M NH4HCO3, and analyzed by HPLC within 24 h. HPLC-based identification and
quantification of ethenylated species were performed with an automated Waters HPLC
apparatus equipped with a fluorescence detector by injection into a 250 mm, 10 μm Hamilton
PRP-X100 anion exchange column using methanol and NH4HCO3 (pH 8.5) as the mobile
phase. Because a component of the Tris buffer caused a fluorescent signal that interfered with
etheno-derivatized adenosine detection, extracellular collections for adenosine assessment
were performed in 10 mM KPO4 (pH 7.6) in lieu of TK buffer.
Invertase Expression
Invertase secretion was assessed in wild-type yeast grown overnight in YP and 2% (w/v)
galactose and then rinsed and resuspended in TK glucose without sugar. Invertase activity was
assessed by removing 20 μL of the cell suspension at various time points and incubating the
samples at 37 °Cin100 μL of 50 mM NaOAc (pH 5.1), 0.1% Triton X-100, and 25 μL of 0.5
M sucrose. After 10 min, 60 μL of 0.5 M KH2PO4 was added to stop the reaction, the samples
were centrifuged to remove cells, and the supernatant was boiled for 2 min. Liberated glucose
was assessed using a glucose oxidase kit from Pointe Scientific (Canton, MI).
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The biochemical assay for UDP-glucose was performed as previously described (28). Samples
(150 μL) were incubated in 25 mM HEPES (pH 7.4), 2 mM MgCl2, 1.6 mM CaCl2, 0.5 unit/
mL UDP-glucose pyrophosphorylase from baker’s yeast (Sigma-Aldrich), and 100 nM [32P]
PPi (200000 cpm). Incubations were terminated by addition of 0.3 mM PPi and heating of
samples for 2 min at 95 °C. Conversion of UDP-glucose to [32P]UTP was assessed using HPLC
(Shimadzu, Kyoto, Japan) via a 3.9 mm × 150 mm Nova-Pack C18 column (Waters, Milford,
MA) with an ion pairing mobile phase (1 mL/min) consisting of 8 mM tetrabutylammonium
hydrogen sulfate, 60 mM KH2PO4 (pH 5.3), and 10% methanol, and radioactivity was
monitored online.
UDP-Glucose Bioassay
The bioassay was developed using yeast strain Cy10981 transformed with a modified P2Y14
receptor (P2Y14-2211) and a FUS1::LacZ construct in a high-copy expression vectors as
previously described (26). The transformed Cy10981 was grown to an OD600 of ∼1.0, washed
twice in sterile water, and resuspended in histidine free selective medium with 10 mM 3-AT
at an OD600 of 0.1. A portion of this culture (1.8 mL) and 200 μL of sample were incubated
for 20–24 h at 30 °C, and growth was measured as OD600.
Deletion Mutants
The YMD8 deletion mutant was created by cloning a genomic fragment containing the
YMD8 gene by PCR (primers, 5′-AGCCAAAAATCTGGCCTATCA-3′ and 5′-
TGGGTGGTATGTTGGAATAGA-3′) from the BY4741 parent strain into the pYES2.1/V5-
His-TOPO vector (Invitrogen, Carlsbad, CA). The bulk of the YMD8 coding region was
removed by restriction digestion with MfeI and BamHI and replaced with the MET15 gene
isolated by PCR (primers, 5′-CGCGAATTCTATCTTCGGATGCAAGGGTT-3′ and 5′-
CGCGGATCCTTTTTCTTCTCGACTGCGAAT-3′) from a genomic S. cerevisiae library in
the YCp50 vector (ATCC, Manassas, VA) and digested with EcoRI and BamHI. The resulting
deletion construct was isolated by PCR using the YMD8 primers described above and
transformed using the TRAFO procedure into a BY4741 or YKO deletion strain as indicated
in the text (29). Successful deletions were isolated by conversion from methionine auxotrophy
and verified by PCR. The novel YEA4 deletion mutant was created by cloning the coding region
of the YEA4 gene by PCR (5′-CGCTCTAGAATGTGGAACTCATAAAAGCA-3′ and 5′-
CGCAAGCTTTCATTTACTTTTCTTTATCGC-3′) into the pYES2.1/V5-His-TOPO vector.
The gene was disrupted by inserting a LEU2 gene isolated by PCR from pRS405 (5′-
GCGGATCCTCCTCCTTTTTCTCCTTCTTG-3′ and 5′-
GCGGATCCTTGTCCTGTACTTCCTTCTTCA-3′)into the BglII site in the YEA4 coding
region. The deletion construct was isolated by PCR and transformed into YKO deletion strains
as indicated in the text, with successful deletions selected by conversion from leucine
auxotrophy and verified by PCR.
Overexpression of Nucleotide-Sugar Transporters
PCR was used to amplify the coding regions of HUT1 (5′
CGCGGATCCATGGCGGGAAGTACATCCAGT-3′ and 5′-
CGCGAATTCCTACGCAGATTTTGCCTTCG-3′) and YEA4 (primers as described above)
which were then cloned into the pYES2.1/V5-His-TOPO vector. The plasmid was transformed
into strain BY4741 by TRAFFO and selected on —ura selective medium. Successful
transformants were grown to confluence in —ura selective medium with galactose as a carbon
source to activate expression of the genes from the GAL1 promoter within the vector.
Extracellular collections were performed as described above using TK buffer and 1% (w/v)
galactose.
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All data are reported as means ± the standard deviation. Differences between groups were
compared using a Student’s t test.
RESULTS
Yeast Release UDP-Glucose
The previously demonstrated ability of yeast to release ATP suggests that this organism may
release other purinergic agonists. To test this hypothesis, we examined the ability of yeast to
release the nucleotidesugar UDP-glucose, the natural agonist of the P2Y14 receptor (30). We
measured extracellular levels of UDP-glucose using a previously described biochemical assay
(28) and compared these results to those for ATP release measured by luminometry. Yeast
incubated in 1% (w/v) glucose released UDP-glucose at a rate that was approximately 1% of
that of ATP under similar conditions (Figure 1A,B). Like that of ATP, release was linear over
1 h. However, in contrast to that of ATP, the rate of release of UDP-glucose was not
significantly decreased in the absence of glucose (Figure 1A,B).
While the significant reduction of the rate of ATP release in the absence of glucose has
previously been interpreted as evidence of glucose-dependent stimulation of nucleotide release
(24,25), we noted yeast incubated in media without glucose are known to have decreased
intracellular concentrations of ATP and increased intracellular concentrations of the lower-
energy adenine nucleotides ADP and AMP (31). To determine if this glucose-dependent pattern
of intracellular adenyl nucleotides impacted efflux, we measured extracellular and intracellular
levels of all adenine nucleotides. As expected, yeast incubated in 1% (w/v) glucose released
predominantly ATP, with very little ADP or AMP (Figure 2A). In contrast, cells incubated in
the absence of glucose released significant quantities of nucleotides, but predominantly as
AMP rather than ATP. Intermediate sugar concentrations [0.1% (w/v) glucose] supported
release of intermediate levels of all three nucleotides. These findings were not likely influenced
by extracellular nucleotide metabolism, since experimental conditions were chosen to
minimize extracellular phosphatase activity (32), and exogenously added ATP (100 nM) did
not undergo significant metabolism (122 ± 43% initial concentration after incubation for 1 h
in TK buffer without glucose). Total adenine nucleotide release was similar at all sugar
concentrations assayed over 1 h, suggesting that the net rate of release of adenine nucleotides
was not influenced by glucose concentration over the relatively short time period of these
experiments. These release patterns reflected the relative composition of intracellular
nucleotide pools; e.g., yeast incubated without glucose accumulated higher levels of
extracellular and intracellular AMP (Figure 2B). However, we also observed that yeast
incubated without glucose retained a fraction of their intracellular nucleotide pool as ATP yet
released AMP almost exclusively, suggesting that not all intracellular pools participate in
release. Adenosine release was assessed independently and did not appear to be significantly
different from zero (1.4 ± 2.1 nM/OD600, n = 4). Overall, these data suggest that neither ATP
nor UDP-glucose release is stimulated by glucose, but that the pattern of nucleotide release
reflects intracellular concentrations. Indeed, preservation of UDP-glucose release in the
absence of extracellular glucose is consistent with previous data suggesting that yeast preserve
intracellular nucleotide sugar concentrations in the absence of an energy source (31).
Yeast Maintain Exocytosis during Short-Term Incubation without Glucose
Exocytosis is a process that requires energy, yet our findings suggested that exocytosis
accounted for adenine nucleotide and UDP-glucose release in the absence of glucose or other
energy sources. We postulated that the yeast in our experiments retained sufficient energy
stores to continue exocytosis over the relatively brief (1 h) period of our experiments, consistent
with our previous observation that a fraction of intracellular ATP was retained after incubation
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in the absence of glucose. To test this hypothesis directly, we examined extracellular
accumulation of the secreted enzyme invertase, commonly used as a marker of yeast secretion.
Because glucose interferes with the invertase assay, we examined secretion in response to
galactose in yeast preconditioned to utilize this sugar as an energy source. In these experiments,
invertase secretion occurred in both the presence and absence of galactose (Figure 2C),
indicating that exocytosis continued under our experimental conditions. It could be argued that
these experiments are not relevant to nucleotide release mechanisms, since yeast were
previously reported not to release ATP in response to galactose (24). However, on the basis of
our previous results, we suspected that this finding reflected the known inability of yeast grown
in glucose-containing media to immediately utilize galactose as an energy source, leading to
low intracellular ATP levels available for release. Indeed, while we verified that yeast grown
in glucose do not release ATP when incubated with galactose, we also demonstrated that
intracellular ATP levels were low under these conditions (Figure 2D). In contrast, yeast
preconditioned to utilize galactose by prior growth in galactose-containing media had
intracellular ATP levels and extracellular release rates similar to those of yeast grown and
incubated in glucose. These findings not only validate the use of galactose in the previous
experiments but also provide further evidence that release of purinergic agonists does not
require glucose specific stimulation.
Mutants That Alter UDP-Glucose Release
To further explore the mechanisms underlying UDP-glucose release, we examined the effect
of mutation of genes encoding the nucleotide sugar transporters known to concentrate these
compounds with the secretory apparatus. We identified eight nucleotide sugar transporter
homologues in S.cerevisiae(33,34) (Table 1). The products of three of these genes have been
shown to transport nucleotide sugars: VRG4 (GDP-mannose) (34), HUT1 (UDP-galactose)
(35), and YEA4 (UDP-N-acetylglucosamine) (36). HVG1 is very similar to VRG4 (92% protein
similarity), although no function has been ascribed to its gene product. Two other genes,
YMD8 and the hypothetical open reading frame YML0138C, have no known function but are
∼40% similar to VRG4. Through BLAST searches (37) with the known nucleotide sugar
transporter homologues, another homologous gene was identified, the hypothetical open
reading frame YDR438W. The last gene, MCH5, is homologous to VRG4 but was recently
identified as a plasma membrane riboflavin transporter and is, therefore, unlikely to be a
nucleotide sugar transporter (38).
UDP-glucose release after incubation in 1% (w/v) glucose was measured in the wild type and
all seven available deletion mutants (VRG4 deletion mutants are not viable). Net UDP-glucose
release after 1 h was not significantly impaired in any mutant; however, the rate of UDP-glucose
release was increased significantly in the ymd8Δ mutant (Figure 3A). Extracellular ATP levels
were similar to that of the wild type in the ymd8Δ strain and all other deletion mutants,
suggesting that the increased rate of UDP-glucose release was not due to nonspecific changes
in membrane permeability (Figure 3A), and no significant extracellular metabolism of UDP-
glucose was detected in either the WT or ymd8Δ strain (the fraction of [3H]UDP-glucose
recovered after incubation for 60 min was 97.9 ± 0.9% for WT and 99.7 ± 0.4% for ymd8Δ).
Like that of the wild type, release of UDP-glucose from the ymd8Δ strain was linear over time
(Figure 3B). To determine if an elevated rate of UDP-glucose release in the ymd8Δ strain
reflected altered intracellular UDP-glucose concentrations, we measured the levels of
extracellular and intracellular UDP-glucose in both the wild type and the mutant after
incubation for 1 h. Interestingly, intracellular UDP-glucose concentrations were elevated in
the ymd8Δ strain relative to that in the wild type, but the relative increase was less than the
relative increase in the extracellular concentration of UDP-glucose (Figure 3C). In other words,
the ymd8Δ strain released a proportionally greater percentage of its intracellular UDP-glucose
over 1 h [3.2 ± 1.2% for ymd8Δ and 0.9 ± 0.4% for WT (p < 0.05)].
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The biochemical assay for UDP-glucose proved to be technically demanding, and to simplify
the analysis, we developed a bioassay for UDP-glucose based on heterologous expression of
the mammalian P2Y14 receptor in specialized yeast strains. For this bioassay, we utilized
engineered yeast strains expressing a modified version of the human P2Y14 UDP-glucose
receptor known to have increased sensitivity to nucleotide sugars (26). Receptor stimulation
in this strain led to expression of the HIS3 gene in a his3Δ background, permitting detection
of receptor activation as growth in histidine deficient media.
To determine the sensitivity and dynamic range of the bioassay, the P2Y14 receptor expression
strain was incubated in histidine deficient media with various concentrations of UDP-glucose,
and growth at 24 h was measured. UDP-glucose could be detected as growth above background
with sensitivity in the low nanomolar range (Figure 4A). We carried out similar experiments
using UDP-galactose and UDP-N-acetylglucosamine. These nucleotide sugars also stimulated
concentration-dependent growth, consistent with their known ligand specificities at the
P2Y14 receptor (26, 30).
To determine if the bioassay could detect UDP-glucose in biological samples, we evaluated
the growth response to extracellular media collected from the wild type (slow UDP-glucose
release) and ymd8Δ strain (fast UDP-glucose release) with UDP-sugar controls. As expected,
the extracellular media from the ymd8Δ strain supported significantly more growth than that
collected from the wild-type strain (Figure 4B). To test specificity, the UDP-sugar standard
solutions and extracellular media were treated with UDP-glucose pyrophosphorylase prior to
the bioassay, which is known to metabolize both UDP-glucose and UDP-galactose but not
UDP-N-acetylglucosamine (39). Treatment with the pyrophosphorylase diminished the
bioassay signals from UDP-glucose and UDP-galactose controls and from extracellular media,
confirming that the bioassay signal was mediated by nucleotide sugars (Figure 4B). As
expected, the bioassay signal from the UDP-N-acetylglucosamine control was not affected by
enzymatic treatment.
UDP-Glucose Release Is Mediated by Nucleotide Sugar Transporters
To determine whether other nucleotide sugar transporters were involved in UDP-glucose
release in the ymd8Δ strain, we deleted the YMD8 gene in each nucleotide sugar transporter
deletion strain to create double deletion mutants and in the wild-type background as a control.
UDP-glucose release after incubation for 60 min in 1% (w/v) glucose was assayed in all using
both the biochemical assay (Figure 5A) and bioassay (Figure 5B). As expected, the new
ymd8Δ mutant exhibited an elevated rate of release of extracellular UDP-glucose, similar to
the YKO YMD8 deletion mutant. The results were similar for the two assays, further confirming
the validity of the bioassay. Compared to that of the ymd8Δ strain, the rate of UDP-glucose
release was decreased modestly in the ymd8Δ/hut1Δ mutant and more significantly in the
ymd8Δ/yea4Δ mutant, though both double deletion mutants exhibited significantly more UDP-
glucose release than wild-type yeast. The other double deletion mutants had elevated rates of
UDP-glucose release, similar to that of the single ymd8Δ mutant. These results suggest that
YEA4, and to a lesser extent HUT1, support the increased rate of release of UDP-glucose in
the ymd8Δ background.
To further examine the contribution of HUT1- and YEA4-encoded transporters to UDP-glucose
release, a hut1Δ/yea4Δ double mutant and a ymd8Δ/hut1Δ/yea4Δ triple mutant were created.
Extracellular UDP-glucose levels in the ymd8Δ/hut1Δ/yea4Δ triple mutant were similar to that
of the ymd8Δ/yea4Δ double mutant, i.e., significantly lower than that of the ymd8Δ single
mutant but higher than that of the wild type (Figure 5B). The hut1Δ/yea4Δ double mutant had
extracellular UDP-glucose release similar to that of the wild type. We therefore conclude that
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the YEA4 gene product mediates most of the excess UDP-glucose release in the ymd8Δ strain,
with the HUT1 gene product playing a lesser role.
The roles of YMD8, YEA4, and HUT1 in UDP-glucose release were further assessed by
overexpressing these genes and measuring the rate of release of UDP-glucose with the bioassay.
Overexpression of YMD8 had little effect on UDP-glucose release in a wild-type strain but did
partially correct the increased rate of release in the ymd8Δ strain (Figure 6A). In contrast,
overexpression of either HUT1 or YEA4 in the wild type led to an increased rate of UDP-glucose
release (Figure 6B).
ATP, AMP, and UDP-Glucose Efflux Are Inhibited by a Biochemical Blockade of Secretion
Previous studies have demonstrated that the rate of release of ATP is decreased by
pharmacological blockade of secretion (24), suggesting that such blockade could alter efflux
of other adenine nucleotides and UDP-glucose. To test this hypothesis, we first verified
previous studies by incubating yeast with the inhibitor of secretion, Brefeldin A (BFA). BFA
does not penetrate the cell membrane of wild-type yeast, and incubation with BFA had no
effect on ATP efflux in wild-type yeast (Figure 7A). Therefore, we used erg6Δ mutants in
which BFA can penetrate the cell and inhibit secretion (40,41). In the erg6Δ mutant, incubation
with BFA caused a substantial decrease in the rate of ATP release in cells incubated with
glucose (Figure 7A) and in the rate of AMP release when cells were incubated in the absence
of glucose (Figure 7B). Similarly, BFA inhibited UDP-glucose release as measured by the
bioassay (Figure 7C). These results indicate that pharmacological blockade of secretion inhibits
release of both nucleotides and nucleotide sugars, consistent with an exocytotic release
mechanism.
DISCUSSION
This study demonstrates that yeast release both adenine nucleotides (ATP and its metabolites)
and a nucleotide sugar (UDP-glucose) into the extracellular medium, representing the first
evidence of UDP-glucose efflux by yeast. Release of UDP-glucose was similar to that of
adenine nucleotides: linear over time and reduced by the secretory inhibitor Brefeldin A. These
similarities suggest that UDP-glucose may share the exocytotic release mechanisms previously
identified for ATP (24). The fact that UDP-glucose release was perturbed by manipulation of
the genes encoding nucleotide sugar transporters lends further support to the involvement of
secretory pathways, since these transporters concentrate nucleotide sugars into the ER or Golgi
compartments (35,36) where they would be available for exocytotic release (28,42). Such
compartmentalization could also explain the discrepancies between intracellular and
extracellular concentrations of adenine nucleotides or UDP-glucose observed under various
experimental conditions.
Our studies suggest that UDP-glucose release is mediated through the Hut1p UDP-galactose
transporter and the Yea4p UDP-N-acetylglucosamine transporter. Although previous reports
indicated that Hut1p and Yea4p transport other nucleotide sugars, our results suggest that these
transporters can also transport UDP-glucose, an activity consistent with broad substrate
specificity observed in nucleotide sugar transporters in other species (43). The HUT1 and
YEA4 gene products are likely not the only UDP-glucose transporters in yeast, since deletion
of both genes did not eliminate efflux of UDP-glucose from either the wild-type or ymd8Δ
strain.
It is not clear why deletion of the YMD8 gene resulted in an increase in the rate of UDP-glucose
release. YMD8 is homologous to known nucleotide sugar transporters (34) and, like other
members of the class, is localized to the Golgi apparatus (44) and interacts with other Golgi
proteins (45). Therefore, YMD8 almost certainly encodes a nucleotide sugar transporter,
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although our data suggest that it is unlikely to transport UDP-glucose. However, its activity
could influence the transport rates of other nucleotide sugar transporters that do transport UDP-
glucose. All known UDP-sugar transporters are UMP antiporters, and transport rates depend
on the intravesicular concentrations of UMP. Loss of YMD8-mediated transport activity in the
ymd8Δ strain could lead to elevated intravesicular UMP levels and increased transport activities
of other UDP-sugar transporters, including those encoded by HUT1 and YEA4. While this
would result in higher intravesicular concentrations of multiple nucleotide sugars, excess UDP-
galactose and UDP-N-acetylglucosamine could be consumed through enzymatic reactions. In
contrast, there are no known intravesicular reactions that utilize UDP-glucose in S.
cerevisiae (16), and even modest increases in transport rates could result in significant
accumulation and release of this nucleotide sugar. This mechanism would also explain why
overexpression of HUT1 or YEA4 causes only a moderate increase in the rate of UDP-glucose
release, since these transporters would have to compete with others for UMP.
UDP-Glucose Bioassay
The studies of UDP-glucose release were greatly facilitated by development of a simple,
sensitive bioassay based on signaling through the P2Y14 receptor. While functional purinergic
receptors have previously been expressed in yeast, this is the first report using a purinergic
receptor bioassay to analyze biologic samples. The assay proved reliable and generated data
comparable to those of a previously established biochemical assay for UDP-glucose. The utility
of this assay will permit future investigations involving large-scale analysis of mutants that
were not feasible with the biochemical assay.
Because yeast are not known to express purinergic receptors, it is not clear why they would
release nucleotides or nucleotide sugars into their environment. Nonreceptor nucleotide-
mediated signaling could occur, and indeed, nucleotide secretion, reuptake, and utilization have
been proposed as a basis for cell-to-cell communication in sporulating yeast (46). Alternatively,
extracellular nucleotides could provide a source of inorganic phosphate for extracellular
enzymatic reactions, which has been observed in Arabidopsis (47). Regardless, these findings
suggest that the mechanisms that support release of nucleotides and nucleotide sugars that
occurred early in evolution are likely found in many cell types. While more complex
mechanisms for regulated release of nucleotides may have evolved later, the efflux pathway
identified here offers the opportunity for genetic and biochemical studies that are not possible
in mammalian cells.
In summary, this study demonstrates that yeast release nucleotides and nucleotide sugars into
the extracellular space via what is most likely an exocytotic release mechanism. The
constitutive efflux may model basal nucleotide and nucleotide sugar release that occurs in many
cell types (2,27), and the genes identified in this study have homologues in mammalian cells
(24,42). These observations suggest that yeast is a model system for studies of the release
mechanisms of compounds that serve as purinergic agonists in vertebrate systems.
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Yeast release UDP-glucose. (A) Yeast were incubated in assay buffer with 0% (○) or 1% (w/
v) glucose (◼) and UDP-glucose levels measured at the indicated times via a biochemical
assay (n = 4). Yeast release UDP-glucose in a linear fashion in both the presence and absence
of glucose. (B) ATP levels in yeast incubated with varying concentrations of glucose were
measured at the indicated times (n = 4). Unlike that of UDP-glucose, the rate of release of ATP
was greatly reduced in the absence of glucose.
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Yeast release adenine nucleotides in a pattern dependent on intracellular adenine nucleotide
concentations. (A) Yeast were incubated in varying concentrations of glucose, and net release
of all adenyl nucleotides after 1 h was measured (n = 4). (B) Intracellular adenine nucleotide
composition of yeast incubated in various glucose concentrations, showing accumulation of
intracellular AMP in cells incubated without glucose (n = 2). (C) Yeast incubated without
glucose continue to secrete over 1 h, as evidenced by increasing invertase activity. Addition
of galactose did not significantly increase the initial secretion rate. Invertase activity actually
stabilized after the 30 min time point, reflecting galactose-induced inhibition of invertase
expression. (D) Yeast were grown in media containing glucose or galactose as indicated in the
figure and then assayed after being incubated for 60 min in buffer containing 1% (w/v)
galactose. Extracellular (black bars, left axis) and intracellular (white bars, right axis) ATP
levels were measured (n = 4). Cells grown in glucose exhibited low extracellular and
intracellular ATP levels in the presence of galactose, but cells grown in galactose have high
intracellular ATP levels and release significant quantities of ATP. An asterisk indicates p <
0.05 vs control.
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Rate of UDP-glucose release increased in the ymd8Δ strain. (A) The net release of UDP-glucose
(gray bars) and ATP (black bars) over 1 h was assessed in the wild-type strain and in deletion
mutants of seven putative nucleotide sugar transporters (n = 4). UDP-glucose release was not
significantly inhibited in any mutants but was accelerated significantly in the ymd8Δ mutant.
(B) Extracellular UDP-glucose (gray symbols) and ATP (black symbols) levels were measured
in both WT (circles) and YMD8 deletion (triangles) strains at the indicated time points (n = 2).
The rate of release of UDP-glucose was linear in both WT and the ymd8Δ mutant but was much
higher in the latter. ATP release was also linear and similar in both strains. (C) Extracellular
(net release over 1 h, black bars) and intracellular (1 h time point, white bars) UDP-glucose
concentrations were assessed in WT and the ymd8Δ mutant (n = 3). Both extracellular and
intracellular UDP-glucose concentrations were elevated in the ymd8Δ mutant, though the
relative increase over that in WT was greater for extracellular than intracellular UDP-glucose.
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Development of a bioassay for UDP-glucose. A bioassay for UDP-glucose was developed
using a yeast strain expressing a modified human P2Y14 receptor (P2Y14 —2211) (26). (A)
The GPCR-sensing strain was incubated for 24 h in histidine deficient media in the presence
of various concentrations of nucleotide sugars. Nanomolar concentrations of nucleotide sugars
stimulate detectable growth, with the following rank potency at low concentrations: UDP-
glucose (UDP-glc) > UDP-galactose (UDP-gal) > UDP-N-acetylglucosamine (UDP-GlcNAc).
(B) Extracellular collections from WT and ymd8Δ mutants were tested in the bioassay with
standards of 10 nM UDP-sugars as controls. The extracellular collection from the ymd8Δ strain
stimulated significant growth in the bioassay, suggesting a high concentration of UDP-glucose
in this sample. The rate of growth in the ymd8Δ extracellular collection and the UDP-glc and
UDP-gal controls was significantly decreased by pretreatment for 30 min at 37 °C with 2 units/
mL UDP-glucose pyrophosphorylase (UDP-Glc PP), demonstrating that the growth signal was
due to the presence of UDP-glucose or UDP-galactose.
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Nucleotide sugar transporters encoded by HUT1 and YEA4 mediate UDP-glucose release in
the ymd8Δ mutant. (A) The biochemical UDP-glucose assay was used to measure the rate of
release of extracellular UDP-glucose in single and double deletion mutants after incubation
for 1 h in 1% (w/v) glucose. An elevated rate of release of UDP-glucose was observed in the
ymd8Δ mutant, while the ymd8Δ/hut1Δ and ymd8Δ/yea4Δ double mutants had rates of release
that were decreased from that of the single ymd8Δ mutant although higher than that of the wild
type (n = 2). (B) The bioassay was used to measure UDP-glucose concentrations in single,
double, and triple deletion mutants after incubation for 1 h in 1% (w/v) glucose. Results were
overall similar to those of the biochemical assay, although the ymd8Δ/hut1Δ mutant was not
significantly different from the ymd8Δ mutant. UDP-glucose release in a ymd8Δ/ hut1Δ/
yea4Δ triple was similar to that of the ymd8Δ/yea4Δ double mutant (n = 3). An asterisk indicates
p < 0.05 vs WT. A dagger indicates p < 0.05 vs ymd8Δ.
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Overexpression of HUT1 and YEA4 nucleotide sugar transporters increases the rate of UDP-
glucose release. (A) A wild-type copy of the YMD8 gene was cloned by PCR into a GAL1
overexpression vector to form the pYMD8 plasmid, which was then transformed into wild-
type and ymd8Δ strains. Cells for the extracellular collection were grown to confluence in
selective media with galactose to induce gene expression. The bioassay was used to detect
UDP-glucose in extracellular collections from 1 h incubations in 1% (w/v) galactose.
Overexpression of YMD8 has no impact on UDP-glucose release in WT strains but did
significantly decrease the rate of release in a ymd8Δ strain (n = 3). (B) Wild-type copies of the
HUT1 and YEA4 genes were cloned into the overexpression vector to form plasmids pHUT1
and pYEA4, which were transformed into wild-type strains. The bioassay was used to detect
extracelluar UDP-glucose in extracellular collections. Both HUT1 and YEA4 overexpression
led to significant increases in the rate of UDP-glucose release (n = 3). An asterisk indicates p
< 0.05 vs vector alone.
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Brefeldin A inhibits ATP, AMP, and UDP-glucose release in susceptible strains. Yeast were
incubated in the presence or absence of 150 μg/mL Brefeldin A (BFA) beginning 2 h prior to
the assay, and net rates of ATP, AMP, or UDP-glucose release were determined after incubation
for 1 h. (A) In cells incubated in 1% (w/v) glucose, incubation with BFA had little impact on
wild-type cells but caused a significant reduction in ATP levels in the sensitive erg6Δ deletion
strain (n = 3). (B) In erg6Δ cells incubated without glucose, BFA inhibited AMP release (n =
5). (C) Incubation with BFA significantly reduced the rate of release of UDP-glucose in the
erg6Δ strain (n = 4). An asterisk indicates p < 0.05.
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Table 1
Nucleotide Sugar Transporter Homologues in S. cerevisiae
gene function gene function
VRG4 GDP-mannose transporter YMD8 unknown




HVG1 unknown MCH5 riboflavin transport
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